Jefferson Center for Vaccines & Pandemic Preparedness
The Sidney Kimmel Medical College established the Jefferson Center for Vaccines & Pandemic Preparedness (formerly the Jefferson Vaccine Center) in 2007 with the goal of combining and further enhancing the existing interest and expertise at Thomas Jefferson University in the area of Vaccine research for infectious diseases, and cancer. The Center combines and utilizes research effort of areas such as immunology, microbial pathogenesis and tumor immunology.
The mission of the Center is to strengthen the basic and translational research at Thomas Jefferson University in vaccinology and therapeutics by establishing cutting edge research program in vaccinomics and building a nationally and internationally known Center of excellence.
A New Coronavirus Vaccine Candidate, CORAVAX™
Jefferson Center for Vaccines & Pandemic Preparedness scientists have created CORAVAX ™, a new coronavirus vaccine by adding a SARS-COV-2 component onto an existing safe and effective vaccine, with established manufacturing hubs, which could help speed global production.
The Center's Research
The Center is dedicated to vaccine research and the related areas of immunology and microbial pathogenesis. We leverage strengths in basic and translational research in providing a forum for open discussions and a focal point in the Philadelphia area for people with these same interests.
Clinical Trials
Learn more about Jefferson clinical vaccine trials and primary care clinical trials.